Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $14.5 in the prior trading day, Orthofix Medical Inc (NASDAQ: OFIX) closed at $14.51, up 0.07%. In other words, the price has increased by $0.07 from its previous closing price. On the day, 1.06 million shares were traded. OFIX stock price reached its highest trading level at $14.69 during the session, while it also had its lowest trading level at $14.38.
Ratios:
Our goal is to gain a better understanding of OFIX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 2.67. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on January 22, 2025, initiated with a Buy rating and assigned the stock a target price of $24.
On November 08, 2024, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $18 to $24.
ROTH MKM Upgraded its Neutral to Buy on May 08, 2024, whereas the target price for the stock was revised from $15 to $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 18 ’25 when Fisher Patrick sold 1,996 shares for $14.21 per share. The transaction valued at 28,363 led to the insider holds 30,116 shares of the business.
Engine Capital Management, LP bought 1,250 shares of OFIX for $13,881 on Jul 02 ’25. The 10% Owner now owns 3,546,057 shares after completing the transaction at $11.11 per share. On Jun 18 ’25, another insider, McPherron Aviva, who serves as the Pres, Global Ops & Qual of the company, sold 3,728 shares for $10.51 each. As a result, the insider received 39,181 and left with 46,322 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OFIX now has a Market Capitalization of 573062272 and an Enterprise Value of 712193792. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 0.88 whereas that against EBITDA is 44.557.
Stock Price History:
The Beta on a monthly basis for OFIX is 0.85, which has changed by -0.1588406 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, OFIX has reached a high of $20.73, while it has fallen to a 52-week low of $10.24. The 50-Day Moving Average of the stock is 22.02%, while the 200-Day Moving Average is calculated to be -3.50%.
Shares Statistics:
The stock has traded on average 422.89K shares per day over the past 3-months and 538300 shares per day over the last 10 days, according to various share statistics. A total of 39.48M shares are outstanding, with a floating share count of 38.70M. Insiders hold about 2.00% of the company’s shares, while institutions hold 91.74% stake in the company. Shares short for OFIX as of 1755216000 were 1982267 with a Short Ratio of 5.71, compared to 1752537600 on 2470409. Therefore, it implies a Short% of Shares Outstanding of 1982267 and a Short% of Float of 5.07.
Earnings Estimates
The stock of Orthofix Medical Inc (OFIX) is currently being evaluated by 2.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.26, with high estimates of $0.38 and low estimates of $0.15.
Analysts are recommending an EPS of between $0.54 and $0.36 for the fiscal current year, implying an average EPS of $0.45. EPS for the following year is $0.44, with 3.0 analysts recommending between $0.45 and $0.43.
Revenue Estimates
5 analysts predict $199.93M in revenue for the current quarter. It ranges from a high estimate of $200.81M to a low estimate of $199M. As of the current estimate, Orthofix Medical Inc’s year-ago sales were $196.61MFor the next quarter, 5 analysts are estimating revenue of $220.66M. There is a high estimate of $226.6M for the next quarter, whereas the lowest estimate is $217.31M.
A total of 5 analysts have provided revenue estimates for OFIX’s current fiscal year. The highest revenue estimate was $816.2M, while the lowest revenue estimate was $811.63M, resulting in an average revenue estimate of $814.61M. In the same quarter a year ago, actual revenue was $799.49MBased on 5 analysts’ estimates, the company’s revenue will be $859.47M in the next fiscal year. The high estimate is $868.27M and the low estimate is $846.73M.
